Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer area. These updates pertain to site release notes and navigation elements, not to core trial data.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page history now shows Revision: v3.3.2 added and Revision: v3.3.1 deleted.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page shows a new revision entry (v3.3.1) and removal of an older revision (v3.2.0); these are internal versioning updates and do not affect the trial data or displayed content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedRemoval of the generic government funding/operating-status notice from the page. This does not affect the study record history or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check67 days agoChange DetectedNew version includes updates to core trial status fields (Study Status and Recruitment Status) in the history, reflecting current changes to the trial's state.SummaryDifference0.1%

- Check95 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference11%

Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.